Case Study

How eConsent Expands Patient Access, Reduces Costs And Improves Time To Treatment


A precision medicine company focused on the development of new therapies for age-related macular degeneration required a deeper understanding of the disease. However, the study design proved to be too expensive and difficult to execute using a traditional trial approach.

Existing study methods required 100+ physical sites, and were limited by patient proximity to those sites, which resulted in the study being delayed for years.

By deploying Medable eConsent, eRecruitment and Direct-to-Patient shipments, the study was able to take place for the first time ever. 


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Hydrocarbon Online? Subscribe today.

Subscribe to Hydrocarbon Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Hydrocarbon Online